FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)
K Number: K260281
·
Decision Mar 26, 2026
Classifications
1
FEI Numbers
23
Registration Numbers
23
Same Product Code
288
Applicant Total
3
Review Days
56
Basic Information
- Device Name
- VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)
- K Number
- K260281
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.1645
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- BIOMERIEUX
- Date Received
- January 29, 2026
- Decision Date
- March 26, 2026
- Product Code
- LON
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LON | System, Test, Automated, Antimicrobial Susceptibility, Short Incubation | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (LON), ordered by most recent decision date.
VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
VITEK COMPACT PRO
FDA 510(k)
FDA Class 2
·Microbiology
BD Phoenix Automated Microbiology System
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by BIOMERIEUX
| K Number | Device Name | ||
|---|---|---|---|
| K141133 | VIDAS H. pylori IgG, VIDAS 3, VIDAS Lyme IgG II, VIDAS RUB IgG, VIDAS TOXO M, VIDAS Human Chorionic Gonadotropin, VIDAS T4, VIDAS Testosterone, VIDAS TSH, and VIDAS D-Dimer Exclusion II | Jul 9, 2015 | Substantially Equivalent |
| K102668 | ETEST TOBRAMYCIN 0.016-256 UG/ML AND 0.064-1024 UG/ML | Nov 17, 2010 | Substantially Equivalent |